EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nisin Inhibition of Gram-Negative Bacteria

Adam M Charest iD, Ethan Reed, Samantha Bozorgzadeh, Lorenzo Hernandez, Natalie V Getsey, Liam Smith iD, Anastasia Galperina, Hadley E Beauregard, Hailey A Charest, Mathew Mitchell iD, Margaret A Riley iD

Microorganisms · 19.06.2024 · 12 (6) · 1230

DOI: 10.3390/microorganisms12061230 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microorganisms, online erschienen am 19.06.2024. Verfasst von Adam M Charest und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, University of Massachusetts, Amherst, MA 01002, USA. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Massachusetts—Amherst Commonwealth Honors College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study investigates the activity of the broad-spectrum bacteriocin nisin against a large panel of Gram-negative bacterial isolates, including relevant plant, animal, and human pathogens. The aim is to generate supportive evidence towards the use/inclusion of bacteriocin-based therapeutics and open avenues for their continued development. Methods and Results: Nisin inhibitory activity was screened against a panel of 575 strains of Gram-negative bacteria, encompassing 17 genera. Nisin inhibition was observed in 309 out of 575 strains, challenging the prevailing belief that nisin lacks effectiveness against Gram-negative bacteria. The genera Acinetobacter, Helicobacter, Erwinia, and Xanthomonas exhibited particularly high nisin sensitivity.

Conclusions

The findings of this study highlight the promising potential of nisin as a therapeutic agent for several key Gram-negative plant, animal, and human pathogens. These results challenge the prevailing notion that nisin is less effective or ineffective against Gram-negative pathogens when compared to Gram-positive pathogens and support future pursuits of nisin as a complementary therapy to existing antibiotics. Significance and Impact of Study: This research supports further exploration of nisin as a promising therapeutic agent for numerous human, animal, and plant health applications, offering a complementary tool for infection control in the face of multidrug-resistant bacteria.

Schlagwörter

Stichwörter der Autor:innen

alternatives to antibioticsantimicrobial resistanceantimicrobialsbacteriabacteriocinsnisin

Autor:innen und Institutionen

  • Department of Biology, University of Massachusetts, Amherst, MA 01002, USA.
  • Organicin Scientific, 240 Thatcher Road, Amherst, MA 01003, USA.

ORCID-Profile: Adam M Charest, Liam Smith, Mathew Mitchell, Margaret A Riley

Förderung

  • University of Massachusetts—Amherst Commonwealth Honors College

Zitieren

APA

Charest, A. M., Reed, E., Bozorgzadeh, S., Hernandez, L., Getsey, N. V., Smith, L., Galperina, A., Beauregard, H. E., Charest, H. A., Mitchell, M., & Riley, M. A. (2024). Nisin Inhibition of Gram-Negative Bacteria. Microorganisms, 12(6), 1230. https://doi.org/10.3390/microorganisms12061230

Vancouver

Charest AM, Reed E, Bozorgzadeh S, Hernandez L, Getsey NV, Smith L, et al. Nisin Inhibition of Gram-Negative Bacteria. Microorganisms. 2024;12(6):1230. doi:10.3390/microorganisms12061230

BibTeX
@article{Charest2024,
  author = {Charest, Adam M and Reed, Ethan and Bozorgzadeh, Samantha and Hernandez, Lorenzo and Getsey, Natalie V and Smith, Liam and Galperina, Anastasia and Beauregard, Hadley E and Charest, Hailey A and Mitchell, Mathew and Riley, Margaret A},
  title = {Nisin Inhibition of Gram-Negative Bacteria},
  journal = {Microorganisms},
  year = {2024},
  volume = {12},
  number = {6},
  pages = {1230},
  doi = {10.3390/microorganisms12061230}
}
Kostenlos starten →